Activity 2: Immunotherapy in advanced urothelial cancer: second-line and beyond

Home Case studies Expert interviews eLearning News Expert challenge Treatment options for metastatic urothelial carcinoma: eLearning activities Activity 2 completed Thank you for completing this activity and evaluation form. Your feedback helps us to deliver the best learning experience. Your result has been logged. HMP Education designates this eLearning programme for a maximum of 1.00 AMA […]

Activity 3: Use of predictive factors for optimal selection of maintenance therapy in patients with mUC

Home Case studies Expert interviews eLearning News Expert challenge Treatment options for metastatic urothelial carcinoma: eLearning activities Activity 3 completed Thank you for completing this activity and evaluation form. Your feedback helps us to deliver the best learning experience. Your result has been logged. HMP Education designates this eLearning programme for a maximum of 1.00 AMA […]

Activity 1: Immunotherapy options in first-line and maintenance therapy for patients with mUC

Home Case studies Expert interviews eLearning News Expert challenge Treatment options for metastatic urothelial carcinoma: eLearning activities Activity 1 completed Thank you for completing this activity and evaluation form. Your feedback helps us to deliver the best learning experience. Your result has been logged. HMP Education designates this eLearning programme for a maximum of 1.00 AMA […]